The healthcare sector in Malaysia is experiencing a surge in demand, driven by a rapidly aging population, a rise in non-communicable diseases, and an increasing need for specialized medical care. Amidst this backdrop, KPJ Healthcare Bhd stands out as a key player, with its recent performance and market position attracting significant attention from investors. However, despite its impressive growth trajectory, the company's stock remains undervalued, according to Phillip Capital's analysis.
In a recent report, Phillip Capital initiated coverage on KPJ with a 'buy' recommendation, highlighting its undervaluation against peers. The stock is currently trading at 34 times projected earnings for 2027, which is below the average of 39 times for local listed private hospital operators. This undervaluation, according to the research house, does not fully capture the company's structural growth prospects.
One of the key factors driving KPJ's growth is its market-leading position in Malaysia. With 30 hospitals and over 3,900 beds, the company commands approximately one-third of the market share in the private hospital sector. This dominance, coupled with an expanding hospital network, positions KPJ to benefit from the growing demand for healthcare services in the country.
The forecast for KPJ's earnings growth is robust, with an estimated average expansion of 8% annually over the next three years. This growth is expected to be driven by higher patient volume and revenue intensity. According to Phillip Capital's estimates, KPJ's net profit could reach RM383 million this year and grow to RM415 million by 2027.
The demographic and health trends in Malaysia provide a strong foundation for KPJ's continued success. The aging population is expected to increase the demand for healthcare services, particularly in the private sector. Additionally, the rising prevalence of non-communicable diseases, such as chronic conditions and mental health issues, further underscores the need for specialized medical care.
In contrast to KPJ, Sunway Healthcare Holdings Bhd, another major player in the private hospital sector, is trading at a higher multiple of 52 times its forward earnings. This disparity in valuation raises questions about the market's perception of the two companies and the potential for KPJ to outpace its competitors in the coming years.
In conclusion, KPJ Healthcare Bhd's undervaluation against peers presents a compelling investment opportunity. The company's market-leading position, expanding hospital network, and favorable industry dynamics position it well to capitalize on the growing demand for healthcare services in Malaysia. As the healthcare sector continues to evolve, KPJ is poised to play a significant role in shaping the future of healthcare in the country.
